Covid-19.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have CT scan or PCR data in accordance with Covid-19 Patients aged 18 to 60 years Patients who have not hypoxemia (oxygen saturation more than 90%)
Exclusion criteria
Exclusion criteria: Patients who taking herbal supplements are excluded Patients who were receiving mechanical ventilation or extracorporeal membrane oxygenation (ECMO) ? are excluded Patients with signs of multiorgan failure at screening (Exclusion criteria included alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels greater than 5 times the upper limit of the normal range or estimated creatinine clearance of less than 50 ml per minute (by the Cockcroft–Gault formula)) are excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improving lung function. Timepoint: Before starting the intervention, Up to 14 days daily after starting the intervention. Method of measurement: Measurement of venous blood Oxygen. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improving clinical performance. Timepoint: Before starting the intervention, Up to 14 days after starting the intervention. Method of measurement: Clinical symptoms include cough, shortness of breath, body aches, headaches, weakness, and body temperature are examined daily. | — |
Countries
Iran (Islamic Republic of)
Contacts
Karaj University of Medical Sciences